| 1 |
32096857 | Screening for Cognitive Impairment in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. | 2020 Feb 25 |
1 |
| 2 |
29247294 | rCBF and cognitive impairment changes assessed by SPECT and ADAS-cog in late-onset Alzheimer's disease after 18 months of treatment with the cholinesterase inhibitors donepezil or galantamine. | 2019 Feb |
1 |
| 3 |
31156366 | Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease. | 2019 |
1 |
| 4 |
26918649 | Efficacy of Cholinesterase Inhibitors in Vascular Dementia: An Updated Meta-Analysis. | 2016 |
1 |
| 5 |
24156269 | The prediction of response to galantamine treatment in patients with mild to moderate Alzheimer's disease. | 2014 Feb |
1 |
| 6 |
24566512 | Cognitive subdomain responses to galantamine in Alzheimer's disease. | 2014 Mar |
1 |
| 7 |
23233806 | Galantamine versus donepezil in Chinese patients with Alzheimer's disease: results from a randomized, double-blind study. | 2012 |
2 |
| 8 |
21222607 | Long-term response to galantamine in relation to short-term efficacy data: pooled analysis in patients with mild to moderate Alzheimer's disease. | 2011 Mar |
2 |
| 9 |
19833161 | Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease. | 2010 Feb 1 |
1 |
| 10 |
19358618 | Optimal dosing of galantamine in patients with mild or moderate Alzheimer's disease: post Hoc analysis of a randomized, double-blind, placebo-controlled trial. | 2009 |
2 |
| 11 |
18308781 | Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6). | 2008 Sep |
1 |
| 12 |
18975103 | Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial). | 2008 Nov |
1 |
| 13 |
17313606 | A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong. | 2007 Mar |
1 |
| 14 |
17664404 | Galantamine treatment of vascular dementia: a randomized trial. | 2007 Jul 31 |
1 |
| 15 |
18427456 | [Efficacy and safety of galantamine (reminyl) in the treatment of dementia in patients with Parkinson's disease (open-label controlled trial)]. | 2007 |
1 |
| 16 |
16323253 | A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease. | 2006 Jan |
1 |
| 17 |
16437436 | Galantamine for Alzheimer's disease and mild cognitive impairment. | 2006 Jan 25 |
1 |
| 18 |
16437493 | Galantamine for vascular cognitive impairment. | 2006 Jan 25 |
1 |
| 19 |
16437532 | Cholinesterase inhibitors for Alzheimer's disease. | 2006 Jan 25 |
1 |
| 20 |
16700849 | Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimen. | 2006 May |
1 |
| 21 |
23862185 | Galantamine for vascular cognitive impairment. | 2006 Jan 25 |
1 |
| 22 |
15990426 | Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease. | 2005 |
1 |
| 23 |
14560062 | Management of patients with Alzheimer's disease plus cerebrovascular disease: 12-month treatment with galantamine. | 2004 |
2 |
| 24 |
14716700 | A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease. | 2004 Jan |
1 |
| 25 |
15353385 | Long-term outcomes of galantamine treatment in patients with Alzheimer disease. | 2004 Sep-Oct |
1 |
| 26 |
15495017 | Galantamine for Alzheimer's disease. | 2004 Oct 18 |
1 |
| 27 |
15598477 | A prospective, double-blind, community-controlled comparison of three doses of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population. | 2004 Oct |
1 |
| 28 |
12566596 | Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months. | 2003 |
5 |
| 29 |
12673604 | The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure. | 2003 Apr |
1 |
| 30 |
12875613 | A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease. | 2003 |
2 |
| 31 |
12962529 | Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease. | 2003 |
1 |
| 32 |
14512822 | Galantamine demonstrates efficacy and safety in elderly patients with Alzheimer disease. | 2003 Jul-Sep |
2 |
| 33 |
11965273 | Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. | 2002 Apr 13 |
1 |
| 34 |
12134305 | [Nicotinic Receptor, galantamine and Alzheimer disease]. | 2002 Jun 1-15 |
1 |
| 35 |
12296613 | Galantamine provides broad benefits in patients with 'advanced moderate' Alzheimer's disease (MMSE < or = 12) for up to six months. | 2002 Sep |
1 |
| 36 |
11571763 | Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease. | 2001 Sep |
1 |
| 37 |
11606667 | Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial. | 2001 Nov |
1 |
| 38 |
11669506 | Maintaining cognitive function in Alzheimer disease: how effective are current treatments? | 2001 Aug |
2 |
| 39 |
10881250 | Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group. | 2000 Jun 27 |
1 |
| 40 |
10881251 | A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group. | 2000 Jun 27 |
1 |
| 41 |
10971048 | Galantamine: additional benefits to patients with Alzheimer's disease. | 2000 Sep |
1 |